1.
Additional file 1 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
2.
Additional file 2 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
Additional file 3 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
Additional file 4 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
Additional file 5 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
Additional file 6 of Donor type and 3-month hospital readmission following kidney transplantation: results from the Netherlands organ transplant registry
Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse aft...
3.
4.
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
5.
6.
7.